Arena Pharmaceuticals (ARNA) Stock: Gaining on Drug Approval

By |July 19th, 2016|

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)

Arena Pharmaceuticals is having a relatively strong day in the market today, and for good reason. Early this morning, the company announced that it had received news from the FDA with regard to a New Drug Application. That news was that the drug prospect had been approved. Today, we’ll talk […]